Why Chart Industries Just Became an $88 Million Bet and 11% Position for a Global Macro Fund

São Paulo-based Absolute Gestao de Investimentos initiated a new position in Chart Industries (GTLS) in Q3, acquiring 440,746 shares valued at roughly $88.22 million (about 11.47% of its 13F-reportable AUM), within a U.S. equity portfolio of 35 positions totaling $769.14 million. Chart trades near $205.85 (market cap ~$9.25 billion) and is in a strong operational run—Q3 orders rose ~44% y/y to $1.68 billion with backlog above $6 billion and adjusted operating margins near 23%—while carrying GAAP losses from one-time costs and a pending $210/share takeover offer from Baker Hughes, creating a modest near-term upside if the deal completes.

Analysis

Market structure: Absolute Gestao’s concentrated buy of GTLS (440,746 shares, $88m; GTLS price $205.85 vs Baker Hughes offer $210) underscores both an arbitrage and sector-consolidation story. Direct beneficiaries are Chart and cryogenic/equipment suppliers (hydrogen, LNG, CO2 capture OEMs) who gain pricing power from a >$6bn backlog and ~44% YoY order growth; large industrial gas conglomerates (Linde/APD) face competitive pressure on specialty niches and aftermarket services.

Risk assessment: Near-term (days–weeks) the dominant risk is deal execution — the $210 bid leaves only ~2% upside, so financing or antitrust issues are low-probability/high-impact negatives; medium-term (months) backlog conversion depends on customer project financing and supply-chain capacity; long-term (3–36 months) secular demand for hydrogen/LNG supports higher structural margins but is cyclical and capex-dependent. Hidden dependency: GTLS top-line visibility is lumpy — backlog >$6bn but revenue realization requires third-party project funding.

Trade implications: For event-driven players the sensible move is a small, disciplined arbitrage: buy GTLS equity sized 1–2% of portfolio within 5 trading days to capture to $210, with stop-loss at $195 and exit on deal close or confirmed delay >60 days. For secular exposure, use limited-risk call strategies (buy Jan 2027 220 LEAPs sized 0.5–1% of portfolio) and hedge with Jan 2026 180 puts covering 25–50% of delta to protect against deal failure; consider a relative value pair long GTLS / short APD (0.5%) to isolate equipment vs. volume-exposed gas producers.

Contrarian angles: The market underestimates conversion risk and overestimates guaranteed upside — $205.85 price leaves scant arbitrage margin vs $210 and liquidity will tighten if deal reduces float. Conversely, secular underpricing exists: if Baker Hughes raises the offer or hydrogen/LNG project awards accelerate, GTLS could re-rate materially; watch two triggers—any bid revision within 90 days and quarterly backlog-to-revenue conversion >20% as signals to add exposure.

Key Decisions for Investors

• Establish a 1–2% portfolio long position in GTLS within 5 trading days as an event-arbitrage trade to capture the $210 Baker Hughes offer; set a hard stop at $195 and exit fully at $210 or if Baker Hughes publicly delays/withdraws the offer by >60 calendar days.
• Allocate 0.5–1% portfolio to GTLS Jan 2027 220 LEAP calls (long-dated calls) to capture secular hydrogen/LNG upside; cap exposure and plan to roll or take profits if GTLS rises >50% or backlog conversion to revenue lags below 15% over 12 months.
• Buy downside protection: purchase Jan 2026 GTLS 180 puts sized to cover 25–50% of the equity position to hedge deal-failure tail risk; if put implied vol rises >40% (relative to historical 30-day vol), reduce put size and reassess cost-benefit.
• Implement a 0.5% pair trade: long GTLS vs short APD (or long GTLS / short LIN if liquidity permits) to express equipment/manufacturing re-rate versus volume-based industrial-gas peers; rebalance if spread moves >10% or relative fundamentals diverge (APD/LIN margin expansion >200bp).